Head & neck · 2026
Active Surveillance in Papillary Thyroid Cancer With Primary Tumors Greater Than 1.5 cm.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sanchez Lina Pedraza, Hintze Justin, Newman Samantha K, Shaha Ashok, Morris Luc G, Tuttle R Michael
Аннотация
BACKGROUND: While accepted as a viable initial management option for properly selected small (< 1.5 cm) papillary thyroid cancer (PTC), the natural history and clinical outcomes of active surveillance in larger tumors are not well described.
METHODS: This is a retrospective chart review of patients with PTC > 1.5 cm opting for active surveillance as part of routine clinical care.
RESULTS: In 45 patients with PTC > 1.5 cm (range 1.6-2.9 cm) followed with active surveillance for a median of 4.2 years: 6 patients (13%, 6/45) demonstrated an increase in tumor volume, 5 patients (11%, 5/45) demonstrated newly identified cervical lymph node metastasis. Only 9 patients (20%, 9/45) transitioned to surgical intervention with no evidence of disease, a median of 3.1 years after surgical intervention.
CONCLUSION: These findings suggest that active surveillance is a viable initial management option in properly selected patients with PTC greater than 1.5 cm in maximal diameter.
METHODS: This is a retrospective chart review of patients with PTC > 1.5 cm opting for active surveillance as part of routine clinical care.
RESULTS: In 45 patients with PTC > 1.5 cm (range 1.6-2.9 cm) followed with active surveillance for a median of 4.2 years: 6 patients (13%, 6/45) demonstrated an increase in tumor volume, 5 patients (11%, 5/45) demonstrated newly identified cervical lymph node metastasis. Only 9 patients (20%, 9/45) transitioned to surgical intervention with no evidence of disease, a median of 3.1 years after surgical intervention.
CONCLUSION: These findings suggest that active surveillance is a viable initial management option in properly selected patients with PTC greater than 1.5 cm in maximal diameter.